Cardlytics reported a revenue of $28.2 million, a 42% decrease year-over-year. The company's FI MAUs increased by 31% to 157.2 million, but ARPU decreased by 55% to $0.18. The company is optimistic about long-term growth due to the launch of Wells Fargo and progress in product development initiatives.
Revenue decreased by 42% year-over-year to $28.2 million.
FI MAUs increased by 31% year-over-year to 157.2 million.
ARPU decreased by 55% year-over-year to $0.18.
Net loss attributable to common stockholders was $(19.8) million, or $(0.73) per diluted share.
Cardlytics anticipates narrowing year-over-year declines in the second half of 2020, driven by the completion of the Wells Fargo launch and advancements in product development.